We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
Cap. Flow
+$7.27B
Cap. Flow %
9.7%
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.04B
2
MSFT icon
Microsoft
MSFT
+$830M
3
AMZN icon
Amazon
AMZN
+$550M
4
JNJ icon
Johnson & Johnson
JNJ
+$483M
5
AAPL icon
Apple
AAPL
+$470M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 13.75%
3 Healthcare 12.4%
4 Financials 7.81%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DC icon
1826
Dakota Gold
DC
$631M
$666K ﹤0.01%
+261,010
New +$695K
CRDF icon
1827
Cardiff Oncology
CRDF
$63M
$663K ﹤0.01%
298,829
-135,753
-31% -$512K
FCG icon
1828
First Trust Natural Gas ETF
FCG
$608M
$663K ﹤0.01%
+25,217
New +$685K
JXN icon
1829
Jackson Financial
JXN
$8.56B
$662K ﹤0.01%
8,915
-8,242
-48% -$589K
COCO icon
1830
Vita Coco
COCO
$3.9B
$661K ﹤0.01%
+23,734
New +$629K
IOO icon
1831
iShares Global 100 ETF
IOO
$8.74B
$661K ﹤0.01%
6,840
-16,960
-71% -$1.56M
CRMD icon
1832
CorMedix
CRMD
$582M
$659K ﹤0.01%
152,275
+79,619
+110% +$404K
ERX icon
1833
PUT
Direxion Daily Energy Bull 2X ETF
ERX
$222M
$657K ﹤0.01%
+10,100
New +$689K
CORT icon
1834
Corcept Therapeutics
CORT
$9.97B
$656K ﹤0.01%
20,200
-78,299
-79% -$2.14M
MDU icon
1835
MDU Resources
MDU
$4.37B
$656K ﹤0.01%
47,190
+25,196
+115% +$348K
RRAC.WS
1836
CALL
DELISTED
Rigel Resource Acquisition Corp Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RRAC.WS
$656K ﹤0.01%
57,908
-92,092
-61% -$24.1K
CMC icon
1837
Commercial Metals
CMC
$7.85B
$656K ﹤0.01%
+11,929
New +$658K
BSLKW
1838
CALL
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$655K ﹤0.01%
59,300
-27,303
-32% -$4.49K
FORM icon
1839
FormFactor
FORM
$6.96B
$652K ﹤0.01%
10,779
-74,934
-87% -$3.91M
PBYI icon
1840
Puma Biotechnology
PBYI
$393M
$652K ﹤0.01%
200,085
-38,406
-16% -$169K
WHF icon
1841
WhiteHorse Finance
WHF
$142M
$647K ﹤0.01%
+52,715
New +$671K
SGRY icon
1842
Surgery Partners
SGRY
$2.05B
$644K ﹤0.01%
27,060
-24,168
-47% -$620K
BATRK icon
1843
Atlanta Braves Holdings Series B
BATRK
$3.28B
$643K ﹤0.01%
+16,300
New +$634K
ABG icon
1844
Asbury Automotive
ABG
$4.37B
$641K ﹤0.01%
+2,815
New +$639K
MSGS icon
1845
Madison Square Garden
MSGS
$9.65B
$640K ﹤0.01%
+3,400
New +$630K
LRCX icon
1846
Lam Research
LRCX
$337B
$639K ﹤0.01%
6,000
-24,570
-80% -$2.36M
SPTN
1847
DELISTED
SpartanNash
SPTN
$638K ﹤0.01%
+34,014
New +$663K
XIFR
1848
XPLR Infrastructure LP
XIFR
$1.1B
$638K ﹤0.01%
+23,085
New +$700K
IESC icon
1849
IES Holdings
IESC
$11B
$632K ﹤0.01%
+4,534
New +$637K
NBN icon
1850
Northeast Bank
NBN
$1.1B
$631K ﹤0.01%
+10,375
New +$572K

Similar funds

Marshall Wace's Q2 2024 Portfolio in Review

As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.

  • Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
  • Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
  • Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
  • Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
  • Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.